Socra CCRP Exam 2026 Questions and
Answers
Contract Research Organization - Correct answer-A person or an organization
(commercial, academic, or other) contracted by the sponsor to
perform one or more of a sponsor's trial-related duties and functions.
When a short form is used for informed consent the witness must sign the short
form or the summary? - Correct answer-False-they must sign both
What is FDA form 3454 - Correct answer-Certification Financial Interests and
Arrangements of Clinical Investigators
What are the three main basic ethical principles of the Belmont Report? - Correct
answer-Respect for persons.
Beneficence.
Justice.
Phase III - Correct answer-Study Participants: 300 to 3,000 volunteers who have
the disease or condition
©COPYRIGHT 2025, ALL RIGHTS RESERVED 1
, Length of Study: 1 to 4 years
Purpose: Efficacy and monitoring of adverse reactions
Phase I - Correct answer-20 to 100 healthy volunteers or people with the
disease/condition.
Length of Study: Several months
Purpose: Safety and dosage
Phase II - Correct answer-Study Participants: Up to several hundred people with
the disease/condition.
Length of Study: Several months to 2 years
Purpose: Efficacy and side effects
©COPYRIGHT 2025, ALL RIGHTS RESERVED 2
Answers
Contract Research Organization - Correct answer-A person or an organization
(commercial, academic, or other) contracted by the sponsor to
perform one or more of a sponsor's trial-related duties and functions.
When a short form is used for informed consent the witness must sign the short
form or the summary? - Correct answer-False-they must sign both
What is FDA form 3454 - Correct answer-Certification Financial Interests and
Arrangements of Clinical Investigators
What are the three main basic ethical principles of the Belmont Report? - Correct
answer-Respect for persons.
Beneficence.
Justice.
Phase III - Correct answer-Study Participants: 300 to 3,000 volunteers who have
the disease or condition
©COPYRIGHT 2025, ALL RIGHTS RESERVED 1
, Length of Study: 1 to 4 years
Purpose: Efficacy and monitoring of adverse reactions
Phase I - Correct answer-20 to 100 healthy volunteers or people with the
disease/condition.
Length of Study: Several months
Purpose: Safety and dosage
Phase II - Correct answer-Study Participants: Up to several hundred people with
the disease/condition.
Length of Study: Several months to 2 years
Purpose: Efficacy and side effects
©COPYRIGHT 2025, ALL RIGHTS RESERVED 2